authors.affiliation: 1 Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Andreas
authors.initials: A
authors.lastname: Plate
authors.affiliation: 1 Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Florence
authors.initials: F
authors.lastname: Vallelian
authors.affiliation: 1 Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Gregor
authors.initials: G
authors.lastname: Herfs
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D005293:Ferritins / Q000097:blood; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D055501:Macrophage Activation Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D010419:Pentamidine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D016706:Still's Disease, Adult-Onset / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D016572:Cyclosporine; D005293:Ferritins; C502936:tocilizumab; D011241:Prednisone
keywords: Hyperferritinämie; Makrophagen-Aktivierungs-Syndrom; Sturm; Zytokin; adult onset Still’s disease; adulter Morbus Still; cytokine storm; hyperferritinemia; macrophage activation syndrome